CTXR

Citius Pharmaceuticals Inc. (CTXR), based in Cranford, New Jersey, is a biopharmaceutical company focused on developing innovative therapies for critical care settings. The company aims to address significant unmet medical needs with a robust pipeline designed to enhance patient outcomes in hospital environments. By utilizing advanced technologies and engaging in strategic partnerships, Citius is positioning itself as a leader in the critical care sector, fostering transformative advancements in patient treatment. With its commitment to innovation and a clear vision for growth, Citius represents an attractive investment opportunity for institutional investors seeking exposure in the biopharmaceutical market.